Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-80
SponsorZhejiang Hospital
About this trial
This study was designed as a single-center retrospective analysis aimed at investigating whether COVID-19 infection increases the risk or burden of radiation-induced pneumonitis in breast cancer patients.
Eligibility criteria
Qualifiers
patients with pathologically or cytologically confirmed primary breast cancer,
aged 18 years or older but younger than 80 years,
with complete and reliable medical records,
for those with COVID-19 infection, documented evidence of a positive test result.
Disqualifiers
concomitant pulmonary malignancies,
a history of prior thoracic radiotherapy,
concurrent pulmonary infections other than COVID-19 during radiotherapy,
missing key data with loss to follow-up,
Trial design
Treatments tested in this trial
- COVID-19
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov